SCHEMBL2834486

SCHEMBL2834486

CC[N+]1(C)CCCC1.COS(=O)(=O)[O-]

nearest known ligand 0.36

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 1/20 0.30
CHRM3 known ✓ P20309 1/20 0.30
KDM4E B2RXH2 1/20 0.36
HTT P42858 1/20 0.33
LMNA P02545 2/20 0.32
KMT2A Q03164 1/20 0.32
TSHR P16473 1/20 0.31
CTDSP1 Q9GZU7 1/20 0.31
BBOX1 O75936 1/20 0.31
CYP2D6 P10635 1/20 0.30
CHRM2 P08172 1/20 0.30
HRH1 P35367 1/20 0.30
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL17102670 0.87 BBOX1 (0.34) KDM4ELMNATSHRCTDSP1BBOX1
Sulfuric Acid SCHEMBL17102587 0.85 TSHR (0.37) KDM4EHTTLMNAKMT2ATSHR
Sulfuric Acid SCHEMBL21195060 0.85 BBOX1 (0.33) KDM4ELMNATSHRCTDSP1BBOX1
SCHEMBL14836885 0.85 BBOX1 (0.33) KDM4ELMNATSHRCTDSP1BBOX1
SCHEMBL23573880 0.84 KDM4E (0.42) KDM4EHTTLMNAKMT2ATSHR
SCHEMBL3048618 0.84 RECQL (0.33) KDM4EHTTLMNAKMT2ATSHR
SCHEMBL14118971 0.83 BBOX1 (0.32) KDM4ELMNATSHRCTDSP1BBOX1
Sulfuric Acid SCHEMBL21195030 0.83 TSHR (0.36) KDM4EHTTLMNAKMT2ATSHR
SCHEMBL16908413 0.83 TSHR (0.36) KDM4EHTTLMNAKMT2ATSHR
Sulfuric Acid SCHEMBL17102675 0.83 BBOX1 (0.36) KDM4EHTTLMNAKMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210395906-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY CUSTOMARRAY INC (US) 2021-12-23 US claimed
EP-2577003-B1 METHOD AND APPARATUS FOR OPERATING A STEAM CYCLE PROCESS WITH A LUBRICATED EXPANDER MAN TRUCK & BUS AG (DE) 2018-07-18 EP claimed
US-9382816-B2 Method and apparatus for operating a steam cycle process with a lubricated expander MAN TRUCK & BUS AG (DE) 2016-07-05 US claimed
US-20150335547-A1 ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS COLGATE-PALMOLIVE COMPANY (US) 2015-11-26 US claimed
EP-2934469-A2 ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS Colgate-Palmolive Company (US) 2015-10-28 EP claimed
WO-2014098871-A2 ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS COLGATE-PALMOLIVE COMPANY (US) 2014-06-26 WO claimed
US-20130341561-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY CUSTOMARRAY, INC. (US) 2013-12-26 US claimed
US-20130263598-A1 Method and Apparatus for Operating a Steam Cycle Process with a Lubricated Expander MAN TRUCK & BUS AG (DE) 2013-10-10 US claimed
EP-2577003-A2 METHOD AND APPARATUS FOR OPERATING A STEAM CYCLE PROCESS WITH A LUBRICATED EXPANDER MAN Truck & Bus AG (DE) 2013-04-10 EP claimed
US-7718579-B2 Electrochemical deblocking using a hydrazine derivative COMBIMATRIX CORPORATION (US) 2010-05-18 US claimed
EP-1869061-A2 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY Combimatrix Corporation (US) 2007-12-26 EP claimed
EP-1805206-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE Combimatrix Corporation (US) 2007-07-11 EP claimed
US-20070034513-A1 Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array COMBIMATRIX CORPORATION 2007-02-15 US claimed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 WO claimed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO claimed
WO-2006105037-A2 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY COMBIMATRIX CORPORATION (US) 2006-10-05 WO claimed
WO-2006031814-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE COMBIMATRIX CORPORATION (US) 2006-03-23 WO claimed
US-20060054511-A1 Electrochemical deblocking using a hydrazine derivative CUSTOMARRAY, INC. 2006-03-16 US claimed
US-20240101999-A1 HIGH EFFICIENCY, SMALL VOLUME NUCLEIC ACID SYNTHESIS THERMO FISHER SCIENTIFIC GENEART GMBH (DE) 2024-03-28 US disclosed
US-20060054511-A1 Electrochemical deblocking using a hydrazine derivative CUSTOMARRAY, INC. 2006-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395906-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY DNMT1, DNASE1, DNPEP CHRM1 4043/4885CHRM3 1982/4885KDM4E 4183/4885
US-20150335547-A1 ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS MCOLN3, TAS2R39, TAS2R40 CHRM1 1418/4885CHRM3 1417/4885KDM4E 2453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.